Vycor Medical (VYCO) Accounts Payables (2010 - 2026)
Vycor Medical's (VYCO) quarterly Accounts Payables came in at $90467.0 in Q1 2026, down 45.22% year-on-year from $165151.0 in Q1 2025, and up 6.74% on a QoQ basis from $84755.0 in Q4 2025.
Vycor Medical (VYCO) Accounts Payables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Accounts Payables data on file, last reported at $90467.0 in Q1 2026.
- On a quarterly basis, Accounts Payables fell 45.22% year-over-year to $90467.0 in Q1 2026; TTM through Mar 2026 was $90467.0, a 45.22% decrease from a year earlier, with the FY2025 full-year figure at $84755.0, down 42.57% from the prior year.
- Accounts Payables for Q1 2026 stood at $90467.0, up from $84755.0 in the prior quarter.
- Over the last five years, Accounts Payables for VYCO reached as high as $219007.0 in Q3 2022 and fell as low as $84755.0 in Q4 2025.
- Historically, Accounts Payables has averaged $141724.3 across 5 years, with a median of $147569.0 in 2024.
- Across the five-year window, Accounts Payables sank 48.07% in 2023 and surged 32.75% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $200044.0 in 2022, then sank by 41.11% to $117801.0 in 2023, then increased by 25.27% to $147569.0 in 2024, then plunged by 42.57% to $84755.0 in 2025, then climbed by 6.74% to $90467.0 in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $90467.0 in Q1 2026, $84755.0 in Q4 2025, and $92821.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 90,467.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90,467.00 |
| Dec 31, 2025 | 84,755.00 |
| Sep 30, 2025 | 92,821.00 |
| Jun 30, 2025 | 110,042.00 |
| Mar 31, 2025 | 165,151.00 |
| Dec 31, 2024 | 147,569.00 |
| Sep 30, 2024 | 150,980.00 |
| Jun 30, 2024 | 154,770.00 |
| Mar 31, 2024 | 147,859.00 |
| Dec 31, 2023 | 117,801.00 |
| Sep 30, 2023 | 113,729.00 |
| Jun 30, 2023 | 123,363.00 |
| Mar 31, 2023 | 160,816.00 |
| Dec 31, 2022 | 200,044.00 |
| Sep 30, 2022 | 219,007.00 |
| Jun 30, 2022 | 147,566.00 |
| Mar 31, 2022 | 182,573.00 |
| Dec 31, 2021 | 227,720.00 |
| Sep 30, 2021 | 188,578.00 |
| Jun 30, 2021 | 217,950.00 |